93 related articles for article (PubMed ID: 11892704)
1. Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon.
Mazzaro C; Colle R; Baracetti S; Nascimben F; Zorat F; Pozzato G
Clin Exp Rheumatol; 2002; 20(1):27-34. PubMed ID: 11892704
[TBL] [Abstract][Full Text] [Related]
2. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
3. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
Mazzaro C; Zorat F; Comar C; Nascimben F; Bianchini D; Baracetti S; Donada C; Donadon V; Pozzato G
J Rheumatol; 2003 Aug; 30(8):1775-81. PubMed ID: 12913934
[TBL] [Abstract][Full Text] [Related]
4. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
5. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
[TBL] [Abstract][Full Text] [Related]
6. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia.
Mazzaro C; Lacchin T; Moretti M; Tulissi P; Manazzone O; Colle R; Pozzato G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S181-5. PubMed ID: 8730503
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia.
Mazzaro C; Pozzato G; Moretti M; Crovatto M; Modolo ML; Mazzi G; Santini G
Haematologica; 1994; 79(4):342-9. PubMed ID: 7528704
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study.
Mazzaro C; Monti G; Saccardo F; Zignego AL; Ferri C; De Vita S; Gabrielli A; Lenzi M; Donada C; Galli M; Pietrogrande M; Pozzato G
Clin Exp Rheumatol; 2011; 29(6):933-41. PubMed ID: 22153224
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
[TBL] [Abstract][Full Text] [Related]
12. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
Sharvadze LG; Gogichaishvili ShSh; Sakandelidze TsG; Zhamutashvili MT; Chkhartishvili NI
Georgian Med News; 2009 Jan; (166):61-4. PubMed ID: 19202222
[TBL] [Abstract][Full Text] [Related]
13. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
[TBL] [Abstract][Full Text] [Related]
14. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
15. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study.
Caniatti LM; Tugnoli V; Eleopra R; Tralli G; Bassi R; De Grandis D
J Peripher Nerv Syst; 1996; 1(2):131-8. PubMed ID: 10975721
[TBL] [Abstract][Full Text] [Related]
16. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
[TBL] [Abstract][Full Text] [Related]
19. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
